Year: 2026
Type: article
Abstract: Extract Interstitial lung disease (ILD) commonly leads to declining lung function and premature death. With therapies to slow progression, early detection and intervention remain the best opportunity to improve patient outcomes. Despite this, patients report significant delays in diagnosis [1, 2], placing them at risk of unnecessary procedures, ineffective and potentially harmful treatments, unchecked progression, and premature death [2–7]. There are several drivers of diagnostic delay, with a delay in pulmonology referral being most common in the primary care setting [7, 8].
Source: European Respiratory Journal
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7159791212
